Skip to main content
Premium Trial:

Request an Annual Quote

Peter Schulz-Knappe, Robert Petcavich, Robert Bondaryk, Nick Roelofs, David Simmons

Proteome Sciences has hired Peter Schulz-Knappe as R&D director and CSO. Schulz-Knappe will join the firm on Aug. 1 and will split his responsibilities between the company’s headquarters in Cobham, UK, and its laboratories in Frankfurt and London.
Schulz-Knappe was CSO and founder of biomarker-discovery firm BioVision prior to its acquisition by Digilab in February. Prior to that, he led the Lower Saxony Institute of Peptide Chemistry.

Robert Petcavich has left his post as senior vice president and CTO at Lumera to pursue other business interests, according to a company statement. Lumera said that it reorganized into two operational business units earlier this year, which placed technology development under the direction of the business unit heads.

Clinical Data has appointed Robert Bondaryk as general manager and unit head of its Cogenics division.
Formerly an executive vice president and general manager of business development at Proteome Systems, Bondaryk also spent time as vice president of life science and drug discovery at Fisher Scientific. He was vice-president of corporate development at Pharm-Eco Laboratories, co-founder and president of Medtech Capital, and senior consultant at Arthur D. Little.

Agilent Technologies has named Nick Roelofs as vice president and general manager of its life sciences solutions division.
Previously, Roelofs was group operations officer for the life science group at Bio-Rad Laboratories. He also served as chief operating officer of Stratagene. He has held senior positions at Applied Biosystems and Baxter Diagnostic.

David Simmons has joined Cellzome as chief scientific officer.
For the past three years, Simmons was vice-president of inflammation discovery research at Wyeth Research and co-chair of the Inflammation Therapeutic Area Leadership team.
Before Wyeth, he was director of research at Celltech and group director of neuroscience research at SmithKline Beecham Pharmaceuticals.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.